A randomized, double-blind, placebo-controlled, crossover study evaluated bone markers of formation and resorption in 17 overweight or obese men without T2DM who received sequence infusions of GIP alone, GLP-1 alone, a combination of GIP and GLP-1, and placebo [72]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.